Mechanistic and Translational Research on Mood and Psychotic Disorders During the Menopausal Transition
National Institutes of Health
Description
This grant opportunity is looking for research on how mood changes, emotional difficulties, and psychosis occur during menopause, aiming to discover new targets for mental health treatments or prevention.
This NOFO seeks research that will advance understanding of the underlying neurobiological and behavioral mechanisms of mood disruption, emotion dysregulation, and psychosis during the menopausal transition and that will identify novel targets for future mental health interventions or prevention…
Source
Grant ID
PAR-25-281
Agency
National Institutes of Health
Subcategory/Subagency
National Institute of Mental Health
Key Dates
Opportunity Released
November 22, 2024
Eligibility
The following categories of applicants are invited to apply:
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Faith-based or Community-based Organizations
- Regional Organizations
- Non-domestic (non-U.S.) Entities (Foreign Organizations)
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
- Non-domestic (non-U.S.) components of U.S. Organizations
Similar opportunities
- Mechanistic and Translational Research on Mood and Psychotic Disorders During the Menopausal Transition (R21 Clinical Trial Optional)
National Institutes of Health
- Early-Stage Testing of Pharmacologic or Neuromodulatory Device-Based Interventions for Mental Illness (R33 Clinical Trial Required)
National Institutes of Health
- NIMH Clinical Trial Pilot Research on Novel Psychosocial Interventions
National Institutes of Health
- Notice of Special Interest (NOSI): Promoting Cardiovascular and Cardiometabolic Health in Early Stages of the Lifecourse: Pre-adolescence Through Adolescence to Young Adulthood
National Institutes of Health
- Notice of Funding Opportunity for Studies on Neuropsychiatric Symptoms in Alzheimer's Disease
National Institutes of Health